Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DGAT1 | O75907 | 2/20 | 0.49 |
| ▸ | LIPG | Q9Y5X9 | 10/20 | 0.39 |
| ▸ | LPL | P06858 | 9/20 | 0.39 |
| ▸ | PDGFRB | P09619 | 1/20 | 0.34 |
| ▸ | KDR | P35968 | 1/20 | 0.34 |
| ▸ | USP30 | Q70CQ3 | 1/20 | 0.34 |
| ▸ | SNCA | P37840 | 1/20 | 0.32 |
| ▸ | IRAK4 | Q9NWZ3 | 1/20 | 0.32 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.31 |
| ▸ | EGFR | P00533 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19295082 | 0.95 | DGAT1 (0.47) | DGAT1LIPGLPLPDGFRBKDR | |
| SCHEMBL19933760 | 0.89 | DGAT1 (0.47) | DGAT1LIPGLPLPDGFRBKDR | |
| SCHEMBL19794327 | 0.89 | DGAT1 (0.47) | DGAT1LIPGLPLPDGFRBKDR | |
| SCHEMBL19295084 | 0.85 | DGAT1 (0.47) | DGAT1LIPGLPLPDGFRBKDR | |
| SCHEMBL21662364 | 0.85 | DGAT1 (0.43) | DGAT1LIPGLPLPDGFRBKDR | |
| SCHEMBL23956048 | 0.82 | DGAT1 (0.44) | DGAT1LIPGLPLPDGFRBKDR | |
| SCHEMBL23956047 | 0.81 | DGAT1 (0.42) | DGAT1LIPGLPL | |
| SCHEMBL21125910 | 0.81 | DGAT1 (0.57) | DGAT1LIPGLPLPDGFRBKDR | |
| SCHEMBL21125909 | 0.81 | DGAT1 (0.67) | DGAT1LIPGLPLPDGFRBKDR | |
| SCHEMBL21662278 | 0.81 | DGAT1 (0.41) | DGAT1LIPGLPL |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11145828-B2 | Metal complexes | MERCK PATENT GMBH (DE) | 2021-10-12 | — | — | US | disclosed |
| US-11024815-B2 | Metal complexes | MERCK PATENT GMBH (DE) | 2021-06-01 | — | — | US | disclosed |
| EP-3507294-B1 | BINUCLEAR AND TRINUCLEAR METAL COMPLEXES COMPOSED OF TWO INTER-LINKED TRIPODAL HEXADENTATE LIGANDS FOR USE IN ELECTROLUMINESCENT DEVICES | MERCK PATENT GMBH (DE) | 2021-02-24 | — | — | EP | disclosed |
| US-10889604-B2 | Binuclear and trinuclear metal complexes composed of two inter-linked tripodal hexadentate ligands for use in electroluminescent devices | MERCK PATENT GMBH | 2021-01-12 | — | — | US | disclosed |
| US-20190252628-A1 | METAL COMPLEXES | MERCK PATENT GMBH (DE) | 2019-08-15 | — | — | US | disclosed |
| EP-3254317-B1 | METAL COMPLEXES | MERCK PATENT GMBH (DE) | 2019-07-31 | — | — | EP | disclosed |
| US-20190202851-A1 | BINUCLEAR AND TRINUCLEAR METAL COMPLEXES COMPOSED OF TWO INTER-LINKED TRIPODAL HEXADENTATE LIGANDS FOR USE IN ELECTROLUMINESCENT DEVICES | MERCK PATENT GMBH (DE) | 2019-07-04 | — | — | US | disclosed |
| US-20180026209-A1 | Metal Complexes | MERCK PATENT GMBH (DE) | 2018-01-25 | — | — | US | disclosed |
| US-20180026209-A1 | Metal Complexes | MERCK PATENT GMBH (DE) | 2018-01-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190202851-A1 | BINUCLEAR AND TRINUCLEAR METAL COMPLEXES COMPOSED OF TWO INTER-LINKED TRIPODAL HEXADENTATE LIGANDS FOR USE IN ELECTROLUMINESCENT DEVICES | PARN, PUF60, PARG | DGAT1 2586/4885LIPG 4374/4885LPL 4558/4885 |
| US-11145828-B2 | Metal complexes | AP1M1, AP2M1, AP3M1 | DGAT1 2072/4885LIPG 3552/4885LPL 3726/4885 |
| US-20190252628-A1 | METAL COMPLEXES | AP1M1, AP2M1, AP3M1 | DGAT1 2072/4885LIPG 3552/4885LPL 3726/4885 |
| US-11024815-B2 | Metal complexes | EXOC4, EXOC3, TIMCC | DGAT1 1835/4885LIPG 4459/4885LPL 4682/4885 |
| US-10889604-B2 | Binuclear and trinuclear metal complexes composed of two inter-linked tripodal hexadentate ligands for use in electroluminescent devices | PARN, PUF60, PARG | DGAT1 2586/4885LIPG 4374/4885LPL 4558/4885 |
| US-20180026209-A1 | Metal Complexes | AP3M1, AP2M1, SOD1 | DGAT1 1328/4885LIPG 3693/4885LPL 3416/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.